LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multiprotein complex that has bipartite DNA binding through ...

Discover how AI-powered ADMET modeling can enable the prediction of toxicity and pharmacokinetics with depth, transparency ...

Researchers identified that triterpene glycosides from the starfish Solaster pacificus can kill drug-resistant prostate ...

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

This study offers useful findings demonstrating the cartilage-protective effects of osteoactivin in inflammatory experimental models. The study provides compelling evidence that osteoactivin may serve ...

Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its flagship cancer research assay that enables comprehensive genomic profiling. Comprehensive ...

New research identifies NF-kappa-B-activating protein-like (NKAPL) as a potent tumor suppressor in non-small cell lung cancer ...

One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and the neonatal Fc receptor (FcRn). FcRn is central to the body’s ability to ...

In this webinar, Kevin Grady and Manisha Nautiyal will outline how to make predictive 3D cell models for therapeutic ...